The Journal of Nuclear Medicine - JNM

The Journal of Nuclear Medicine - JNM Founded in 1960, The Journal of Nuclear Medicine is the world’s leading nuclear medicine, molecular i

According to new data announced by Clarivate in the 2020 Journal Citation Reports™ (released in June 2021), JNM ranks third in impact among 134 medical imaging journals worldwide. Impact factor – 10.057
Five-year impact factor – 8.573
Immediacy index – 4.011
Total citations – 32,949
Eigenfactor Score – 0.03249
Article Influence Score – 2.19

SSTR-targeted treatment with PRRT is unlikely to be effective for most patients with metastatic extrapulmonary neuroendo...
06/16/2026

SSTR-targeted treatment with PRRT is unlikely to be effective for most patients with metastatic extrapulmonary neuroendocrine carcinoma. Learn more: https://ow.ly/emTz50Zcfkp

The Illustrated Post: First images on a next-generation extended–field-of-view digital bismuth germanium oxide total-bod...
05/25/2026

The Illustrated Post: First images on a next-generation extended–field-of-view digital bismuth germanium oxide total-body PET/CT. https://ow.ly/TQBv50YY8PG

The Illustrated Post: Widespread prostate cancer osseous metastases: Negative on ¹⁸F-piflufolastat PET but positive on ¹...
05/22/2026

The Illustrated Post: Widespread prostate cancer osseous metastases: Negative on ¹⁸F-piflufolastat PET but positive on ¹⁸F-fluciclovine PET. https://ow.ly/upFL50YY8NX

The Illustrated Post: ⁶⁸Ga-DOTA-5G PET/CT detects brain and bone metastases in a patient with metastatic pancreatic canc...
05/18/2026

The Illustrated Post: ⁶⁸Ga-DOTA-5G PET/CT detects brain and bone metastases in a patient with metastatic pancreatic cancer. https://ow.ly/WqP050YY8MS

¹⁷⁷Lu-PSMA–associated thrombotic microangiopathy is a rare but a potentially severe complication of treatment; early dos...
05/14/2026

¹⁷⁷Lu-PSMA–associated thrombotic microangiopathy is a rare but a potentially severe complication of treatment; early dosimetry may help identify at-risk patients. https://ow.ly/99iZ50YY8Mj

Lack of LAT1 and CD98hc expression on tumor cells of diffuse glioma: Revisiting the molecular basis for amino acid PET i...
05/12/2026

Lack of LAT1 and CD98hc expression on tumor cells of diffuse glioma: Revisiting the molecular basis for amino acid PET imaging and theranostics. https://ow.ly/YwsM50YY8Lv

PET imaging can noninvasively quantify both dose- and TB-driven variability in target engagement, supporting personalize...
05/04/2026

PET imaging can noninvasively quantify both dose- and TB-driven variability in target engagement, supporting personalized dosing of PSMA-targeted antibodies and antibody–drug conjugates in patients. https://ow.ly/hCoj50YPt4K

Discussion with Leaders: Toni Choueiri talks with Ken Herrmann about the evolution of genitourinary oncology. https://ow...
05/01/2026

Discussion with Leaders: Toni Choueiri talks with Ken Herrmann about the evolution of genitourinary oncology. https://ow.ly/JZOj50YPt1G

Researchers have developed a multiplex imaging platform that enables single-cell analysis of therapeutic antibody delive...
04/30/2026

Researchers have developed a multiplex imaging platform that enables single-cell analysis of therapeutic antibody delivery and pharmacodynamics in human FFPE tissues. Read more: https://ow.ly/t31g50YPsYg.

Address

Reston, VA
20190

Website

Alerts

Be the first to know and let us send you an email when The Journal of Nuclear Medicine - JNM posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share